You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
A SURGICEL absorbable haemostat for every bleeding situation need

The structure of SURGICEL Powder Absorbable Haemostat allows it to penetrate the surface of the blood to get to the source of bleeding21,22
SURGICEL Powder Absorbable Haemostat penetrates through the blood to stop bleeding at the source, effectively achieving haemostasis in a wet field4-6* Preclinical animal study suggests that SURGICEL Powder Absorbable Haemostat provides 52% faster time to haemostasis than SURGICEL Original Absorbable Haemostat7¥ Easy application across both open and laparoscopic procedures8-11

Easy handling, conformability, and insertion through trocars makes SURGICEL SNoW ideal for minimally invasive surgery12-14≠±
Smart design for optimized handling, conformability, and use in minimally invasive procedures12-14≠±
One layer of SURGICEL SNoW is more effective* at achieving haemostasis than 4 layers of SURGICEL Original15≥

Dissolves into bleeding tissue for precise control16,17
Lightweight layers of SURGICEL FIBRILLAR can be pulled apart and manipulated for intentional precise placement.13 A versatile option for controlling oozing bleeding at multiple sites17 A small amount of SURGICEL FIBRILLAR can be effective in controlling oozing bleeding18

Dense material of SURGICEL NU-KNIT provides strength13,19,20≤
The dense material of SURGICEL NU-KNIT was designed to control more severe continuous bleeding situations13,19,20≤ Thicker and Heavier with 3 x higher tensile strength than SURGICEL Original20
References
*as demonstrated in vitro
¥Pivotal study comparing performance of SURGICEL™ Powder to SURGICEL™ Original in a swine acute liver abrasion model
≠Compared to SURGICEL™ Original
±81% of the interviewed Surgeons described that SURGICEL™ SNoW is quicker and easier to apply endoscopically than SURGICEL™ Original and SURGICEL™ Fibrillar
≥Reduced time to successfully achieve haemostasis under controlled conditions in a porcine splenic incision model. The ORC devices were applied in addition to gauze and the application of digital pressure
≤Compared to the rest of the SURGICEL™ Family
1. Ethicon, 15-0120, Pivotal study comparing performance of SURGICEL™ Powder Absorbable Hemostatic Powder to ARISTA™Absorbable Hemostatic Particles and PerClot® Polysaccharide Hemostatic System in a swine acute live biopsy model, September 2015, Data on File (169841-210309)
2. Ethicon, 15-0061, Pivotal Study Comparing Performance of SURGICEL™ Powder-Absorbable Hemostatic Powder to SURGICEL™ Original Absorbable Hemostat in a Swine Acute Liver Abrasion Model, September 2015, Data on File (169841-210309)
3. Ethicon, 18082018, Surgicel™ Technical Report, Aug 2018, Data on File (169841-210309)
4. Ethicon, 25_2-59164 Surface energy/tension analysis among ORC Aggregate, ORC Fine Fiber, and Arista – Project PIXIE, March 2017, Data on File (116968-210716)
5. Compacted Hemostatic Cellulosic Aggregates available from https://patents.justia.com/patent/20170128618 [accessed 07 July 2021] (116968-210716)
6. Wang A.et al, Absorbable Hemostatic Aggregates, Sci. Eng. 2017;3;3675−3686 (116968-210716)
7. Ethicon, 15-0061, SURGICEL™ Powder versus SURGICEL™ Original. Final Report, September 2015, Data on File (079005-200928)
8. Ethicon, 08032016, SURGICEL™ Powder versus Competitive Powdered Hemostats. Final Report, PSE Accession No. 16-0006, Project No. 16438, March 2016, Data on File (080596-170919)
9. Ethicon, 100294016 Rev6, Design Requirements Matrix Project Pixie: SURGICEL™ Powder, Dec 2016, Data on File (080596-201109))
10. Ethicon, K-5678 Surgicel™ Endoscopic Applicator Summative Usability Design Validation Surgeon and Nurse Study, December 2016, Data on File (080596-201109)
11. Ethicon, 100179522, VOC Summary reflecting DRM, May 2015, Data on File (080596-201109)
12. Ethicon, 12072012, Biosurgery SNoW Marketing Claims Report, July 2012, Data on File (161906-201207)
13. Ethicon, 18082018, SURGICEL™ Technical Report, Aug 2020, Data on File (161906-201207, 161914-201207, 165127-210121)
14. Ethicon, 13102010, SURGICEL™ SNoW™ Absorbable Hemostat – Surgeon Evaluation, Phase 1 and Phase 2, Oct 2010, Data on File (161906-201207)
15. Hutchinson RW et al, Hemostatic efficacy and tissue reaction of oxidized regenerated cellulose hemostats, Cellulose. 2012;10.1007/s10570-012-9828-8 (091518-180509)
16. Ethicon, 18082018, SURGICEL™ Technical Report, Aug 2018, Data on File (144617-200624)
17. Amar PA, Levy ML, Applications of Topical Hemostatic Agents in Neurosurgery, Contemporary Surgery. 1996;4;1-3 (144617-200624, 144616-200624)
18. As Per Instructions For Use (170059-210310)
19. Ethicon, 30092009, Competitive Assessments of Hemostatic Products, September 2009, Data on File (165127-210121)
20. Ethicon, 15072009, Tensile strength comparison of SURGICEL™ ORIGINAL and SURGICEL™ NU-KNIT™, July 2009, Data on File (165127-210121, 165124-210121)
21. Ethicon, 18022016, Surface Energy/Tension Analysis among ORC Aggregate, ORC Fine Fiber and Arista – Project PIXIE, Feb 2016, Data on File (079001-201014)
22. Compacted Hemostatic Cellulosic Aggregates available at https://patents.justia.com/patent/20170128618 [accessed 02 October 2020] (079001-201014)
190463-210924
© Johnson & Johnson Medical NV., 2023.
This site is published by Johnson & Johnson Medical N.V., which is solely responsible for its contents and is intended for EMEA audiences only. This site is intended for Healthcare Professionals. If you are a patient, it is important that you discuss information about the benefits and risks of products with your doctor.
The third-party trademarks used herein are trademarks of their respective owners. Data and usage fees may apply. See your carrier for more information.
*As of March 2017, per internal research conducted by Ethicon.
Please refer always to the Instructions for Use / Package Insert that come with the device for the most current and complete instructions.